Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Genentech Out-Licenses PI3K Inhibitor To Novogen

Executive Summary

The Australian firm also buys out Glioblast to add to its capabilities in brain cancer. Meanwhile, India’s Sun Pharmaceutical acquires Auven’s Ocular Technologies, and GlaxoSmithKline partners with Fimbrion in urinary tract infections and with Zai Lab in autoimmune disorders.

Advertisement

Related Content

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds
Deal Watch: Bristol Leaves Neuropathic Pain Candidate To Lexicon
‘Open Science’ In Action: Allergan Exercises Option For Motus After Gastroparesis Study
Astellas Grows Oncology Portfolio With Ganymed Purchase
Tech Transfer Roundup: Inside Merck’s Approach To Academic Partnering
Sun Set For US Eye-care Push With BromSite Approval
CHMP Green Lights Servier's Lonsurf
Sun Trumps Canadian Rival To Acquire InSite

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097576

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel